en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank


 
5/2011
vol. 49
 
Share:
Share:
more
 
 
abstract:
Review paper

Advances in diagnosis and treatment of reactive arthritis

Brygida Kwiatkowska
,
Maria Maślińska

Reumatologia 2011; 49, 5: 354–360
Online publish date: 2011/09/27
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Reactive arthritis (ReA) is one of the seronegative spondyloarthropathies. ReA is an autoimmune arthritis, frequently preceded by a bacterial infection of the gastrointestinal or genitourinary tract. In 65-85% of patients suffering from ReA, HLA-B27 antigen is present. ReA is a disease with diverse clinical manifestations of the peripheral joints, spine, skin, eyes, digestive and other systems. A variety of symptoms means that patients, especially at the initial stage of the disease, are treated by specialists of different fields of medicine. The clinical picture of ReA is similar irrespective of the preceding infection type, but the therapy depends on the type of bacteria triggering the infection. Chlamydia infection may be persistent and treatment of Chlamydia-induced ReA is based on antibiotics. In other cases, the use of antibiotics is controversial. The course of ReA can be acute and often self-limiting. In some patients, a chronic arthritis develops. Early diagnosis of ReA and its effective treatment may prevent the development of chronic disease and lead to curing the disease completely.
keywords:

reactive arthritis, Reiter’s syndrome, spondyloarthropathies, infection related arthritis







Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.